Back to all assets

Illumina, Inc. ILMN

equity

Price History

The shaded fan is where this price has historically travelled over the months after a close like today’s. It is not a forecast: it has no view on direction, only on distance.

$77.6$186.32$295.04$403.75
2021-102026-09 · $239.62

Over 3 months from Sep 2026, roughly two-thirds of past moves landed between $189.38 and $303.2; nine in ten between $162.71 and $352.89.

Tested against this asset’s own history: across 300 past 3-month windows, the price actually landed inside the two-thirds band 67% of the time. The gap from 68% is the model’s error — real returns have fatter tails than the maths assumes, so the band gets breached more often than it claims.

Time underwater

How far below its previous all-time high the price sat, each month. 0% means a new high.

-95.6%-63.7%-31.9%0.0%
2000-072026-09 · -50.3%

Worst drawdown: −96%, peaking Sep 2000 and bottoming Apr 2003 — 82 months below the prior high before recovering.

DCA Backtest

Invested
$31,500
Value today
$593,708
Return
+1784.8%
Months invested
315

Scenarios

Inflation — the same contributions merely keeping pace with CPI would be $45,752 today, so the real (inflation-adjusted) return is +1197.7%.

Lump sum instead — $31,500 all at once in Jul 2000: $443,393 (+1307.6%) — DCA came out ahead.

Worst timing — same monthly amount started at the all-time high (Jul 2021): $9,915 on $6,300 invested (+57.4%).

⚠ Price returns only — dividends are not included. This understates the true return of dividend-paying shares, and any comparison against crypto (which pays no dividends) is biased against equities by roughly the dividend yield, compounded.

If this saved you a spreadsheet — buy me a coffee.

Every start month at once

Each cell is the return-to-date of £/$/€100-a-month DCA started that month. Click a cell to load it in the backtest above. The ringed cell is the all-time-high start — the worst timing scenario.

JFMAMJJASOND
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Legend:−50%−20%0%+50%+200%+1000%worst timing (ATH)Selected 2000-07: +1784.8%

About Illumina, Inc.

Illumina, Inc. (ILMN) is a listed company categorised under health care and life sciences tools & services, with a market cap of about $36.2B.

There isn’t enough researched data to give it an overall rating yet — only 45% of the scoring weight is backed by facts, below the 60% needed. The score shown is partial and covers only what’s known.

What pushes the score up: market / volatility (4.3/5) and sector / regulatory (3.0/5).

Scoring well: liquidity at 1.0/5.

Not yet researched: leverage / financial, earnings quality, concentration, governance. These are excluded from the score rather than guessed, so the real risk may be higher than what’s shown.

Ratings summarise sourced facts against fixed rules — not investment advice, and no substitute for your own diligence.

Risk Profile

Partial 2.9/5(45%)

Only 45% of the weighting is fact-backed so far — not enough for an overall rating. The partial score covers the rated categories below; the unrated ones may be where this asset’s real risk sits.

How these ratings work

Market / Volatility4.3/5 · weight 20%
  • Annualised volatility (3yr)4/547.1
  • Max drawdown from ATH5/595.6
  • Beta vs S&P 5004/51.3
Liquidity1.0/5 · weight 15%
  • Avg daily $ volume1/5397.4m
  • Float % of shares outstandingnot yet researched
Leverage / Financialunrated · weight 20%
  • Debt / equitynot yet researched
  • Interest coverage (EBIT / interest)not yet researched
Earnings Qualityunrated · weight 15%
  • 3yr EPS volatilitynot yet researched
Concentrationunrated · weight 10%
  • Largest customer, % of revenuenot yet researched
  • Geographic revenue concentrationnot yet researched
Governanceunrated · weight 10%
  • Board independence %not yet researched
  • Share structurenot yet researched
  • Litigation / audit historynot yet researched
Sector / Regulatory3.0/5 · weight 10%
  • Sector regulatory exposure3/5elevated

Linked Assets

Same sector, or return-correlated — worth knowing what else might move if this one does.